Progress in the Treatment of Follicular Lymphoma

/ 1:03:12

Overview of Follicular Lymphoma, in the Context of COVID-19
Treatment Options for Newly Diagnosed
Treatment Options for Relapsed/Refractory Disease
Clinical Trial Updates
How Research Contributes to Your Treatment Options
New & Emerging Treatments
Factors that May Affect Treatment Planning
Side Effect Prevention & Management
Tips to Improve Communicating with Your Health Care Team
The Importance of Communication, in the Context of COVID-19, with the Role of Telehealth/Telemedicine Appointments
Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology & List of Questions
Key Questions to Ask Your Health Care Team
Practical and Psychosocial Support to Cope with Follicular Lymphoma
Questions for Our Panel of Experts

Peter Martin, MD

Chief, Lymphoma Program, Associate Professor of Medicine, Weill Cornell Medicine, Associate Attending Physician, NewYork-Presbyterian Hospital

John M. Pagel, MD, PhD, DSc

Chief of Hematologic Malignancies Program, Director, Stem Cell Transplantation, Swedish Cancer Institute

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

This workshop was originally recorded on March 22, 2021.

CancerCare